Literature DB >> 26068700

Meta-Analysis of the Impact on Mortality of Noninfarct-Related Artery Coronary Chronic Total Occlusion in Patients Presenting With ST-Segment Elevation Myocardial Infarction.

Stephen A O'Connor1, Philippe Garot2, Francesca Sanguineti2, Loes P Hoebers3, Thierry Unterseeh2, Hakim Benamer2, Bernard Chevalier2, Thomas Hovasse2, Marie-Claude Morice2, Thierry Lefèvre2, Yves Louvard2.   

Abstract

Several observational studies have compared clinical outcome in patients with a co-existing noninfarct-related artery chronic total occlusion (n-IRA CTO) versus those without, suggesting increased all-cause mortality. The goal of this study was to provide a systematic review and meta-analysis evaluating the impact of the presence of an n-IRA CTO on short- and long-term mortality after primary percutaneous coronary intervention. Studies published from January 1980 to January 2014 that compared the incidence of all-cause mortality in patients with ST-segment elevation myocardial infarction with co-existing n-IRA CTO versus those without were identified using an electronic search and reviewed using meta-analytical techniques. Seven studies (5 observational studies and 2 observational analyses of randomized controlled trials) comprising 14,117 patients and 1,554 patients (11.7%) with n-IRA CTO were included. The presence of n-IRA CTO was associated with increased incidence of all-cause mortality at a median follow-up of 25.2 months (interquartile range 24 to 60) compared with no CTO (absolute risk 23.5% vs 9.0%; odds ratio [OR] 2.90, 95% confidence interval [CI] 2.09 to 4.01; p <0.0001). This finding was consistent in the analysis of studies reporting 30-day follow-up (absolute risk 17.2% vs 4.7%; OR 3.79, 95% CI 3.13 to 4.59; p <0.0001). Co-existing n-IRA CTO was also associated with increased mortality in a subanalysis of patients with multivessel disease only (absolute risk 24.2% vs 11.3%; OR 2.23, 95% CI 1.90 to 2.63; p <0.0001). In conclusion, coronary CTO in the nonculprit artery in patients presenting with ST-segment elevation myocardial infarction is associated with increased short- and long-term all-cause mortality.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26068700     DOI: 10.1016/j.amjcard.2015.03.031

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Chronic total occlusion: no more meta-analysis, please-a randomized clinical trial is urgently needed.

Authors:  Alfredo Bardají; Gil Bonet
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

Review 2.  Approach to CTO Intervention: Overview of Techniques.

Authors:  Aris Karatasakis; Barbara Anna Danek; Dimitri Karmpaliotis; Khaldoon Alaswad; Minh Vo; Mauro Carlino; Mitul P Patel; Stéphane Rinfret; Emmanouil S Brilakis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-01

3.  Staged Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With ST-Segment-Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis.

Authors:  Pedro A Villablanca; Wilman Olmedo; Michael Weinreich; Tanush Gupta; Divyanshu Mohananey; Felipe N Albuquerque; Ibrahim Kassas; David Briceño; Cristina Sanina; Thomas A Brevik; Emily Ong; Harish Ramakrishna; Michael Attubato; Mark Menegus; Jose Wiley; Ankur Kalra
Journal:  J Am Heart Assoc       Date:  2018-04-13       Impact factor: 5.501

4.  Long-term outcomes of staged recanalization for concurrent chronic total occlusion in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.

Authors:  Kong-Yong Cui; Fei Yuan; Hong Liu; Feng Xu; Min Zhang; Wei Wang; Ming-Duo Zhang; Yun-Lu Wang; Dong-Feng Zhang; Xiao Zhang; Jin-Fan Tian; Shu-Zheng Lyu
Journal:  J Geriatr Cardiol       Date:  2020-01       Impact factor: 3.327

5.  The 11-Year Prognostic Impact of Chronic Total Occlusion in the Noninfarct-Related Coronary Artery on Patients with Acute Myocardial Infarction.

Authors:  Xuanqi An; Jingang Yang; Kefei Dou; Yuejin Yang
Journal:  J Interv Cardiol       Date:  2021-03-17       Impact factor: 2.279

Review 6.  Chronic total occlusion percutaneous coronary intervention in everyday clinical practice - an expert opinion of the Association of Cardiovascular Interventions of the Polish Cardiac Society.

Authors:  Leszek Bryniarski; Maksymilian P Opolski; Jarosław Wójcik; Maciej Lesiak; Tomasz Pawłowski; Jakub Drozd; Wojciech Wojakowski; Sławomir Surowiec; Maciej Dąbrowski; Adam Witkowski; Dariusz Dudek; Marek Grygier; Stanisław Bartuś
Journal:  Postepy Kardiol Interwencyjnej       Date:  2021-03-27       Impact factor: 1.426

Review 7.  Chronic total occlusion revascularization: A complex piece to "complete" the puzzle.

Authors:  Iacopo Muraca; Nazario Carrabba; Giacomo Virgili; Filippo Bruscoli; Angela Migliorini; Matteo Pennesi; Giulia Pontecorboli; Niccolò Marchionni; Renato Valenti
Journal:  World J Cardiol       Date:  2022-01-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.